CRISPR-Cas9

David BIKARD (Institut Pasteur): Studying and fighting pathogenic bacteria with the help of CRISPR

Submitted by AdminSB on Mon, 28/08/2017 - 17:34

Language English

Hervé SEITZ (IGH): Introduction to CRISPR-mediated genome editing

Submitted by AdminSB on Mon, 28/08/2017 - 17:33

Language English

Rosemary KIERNAN et Hervé SEITZ (IGH): Use of CRISPR/Cas9 to probe the miRNA pathway

Submitted by AdminSB on Mon, 28/08/2017 - 17:33

Language English

Jose-Juan LOPEZ-RUBIO (MIVEGEC): A bad day for malaria parasites: CRISPR-Cas9 genome editing to unraveling malaria pathogenesis and drug-resistance causality

Submitted by AdminSB on Mon, 28/08/2017 - 17:32

Language English

Isabelle BUSSEAU et Bernd SCHUTTENGRUBER (IGH): CRISPR-Cas9 technology to address complex genome regulation in Drosophila

Submitted by AdminSB on Mon, 28/08/2017 - 17:32

Language English

Christophe PÉRIN (AGAP), Hervé ETIENNE (IPME) et Sébastien CUNNAC (IPME): CRISPR-Cas9 in plants : the future is today

Submitted by AdminSB on Mon, 28/08/2017 - 17:31

Language English

Thomas ROBERT (IGH): CRISPR-Cas9 and the generation of mouse mutant lines for genetic studies

Submitted by AdminSB on Mon, 28/08/2017 - 17:30

Language English

Philippe BESSIERE (Intellectual property company/ Cabinet REGIMBEAU): Impact of CRISPR-Cas9 patent(s) and related decisions on R&D Gene Editing Technologies

Submitted by AdminSB on Mon, 28/08/2017 - 17:29

Language English

About us

Based on the basis of IFR 119 "Montpellier-Environnement-Biodiversité" (2001-2010), the LabEx CeMEB (Mediterranean Center for the Environment and Biodiversity) brings together ten research units from the Montpellier region .

Contact

Université Montpellier

LabEx CeMEB - Case courrier 07014

163 rue Auguste Broussonnet

34095 Montpellier Cedex , France

Tél. :+33 (0)4 34 43 34 77